Literature DB >> 7110367

Analysis of the 5-hydroxytryptamine induced contraction of the human basilar arterial strip compared with the rat aortic strip in vitro.

C Forster, E T Whalley.   

Abstract

1) Experiments were performed to investigate the nature of the contraction produced by 5-hydroxytryptamine in the human basilar arterial strip in vitro and to compare it with that produced in the rat aortic strip in vitro. 2) The human basilar arterial strip was found to be significantly more sensitive to 5-HT compared to the rat aortic strip. 3) Methysergide, cyproheptadine and methergoline were competitive, selective antagonists against 5-HT on the rat aorta with pA2 values of 7.97, 8.76 and 9.49 respectively. In contrast 5-HT was antagonised by these agents in a manner which was not competitive on the human basilar artery. Both 5-HT and NA were antagonised by BW 501 C67 (alpha-anilino-N-2-m-chlorphenoxy propylacetamide hydrochloride) in a manner which was not competitive on both rat aortic and human basilar arterial strips. 4) Phentolamine (10(-7) to 10(-5) M) was found to be a competitive antagonist against noradrenaline on both the rat aortic strip (pA2 6.9) and the human basilar arterial strip (pA2 7.3). Phentolamine at 10(-5) M shifted the 5-HT curve on the human basilar artery to the right with a reduction in maximum response. 5) Methysergide (10(-9) to 10(-4) M) was found to possess contractile activity on some human basilar arterial strips, the maximum response being approximately 60% of that produced by 5-HT. Phentolamine at 10(-5) M shifted the dose-response curve to methysergide to the right with a slight reduction in the maximum response obtained. 6) The results from this study suggest that the receptor(s) mediating 5-HT-induced contraction of the human basilar artery may be different from the classical "D-receptor" which mediates contraction to 5-HT on the rat aorta.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110367     DOI: 10.1007/bf00491471

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein.

Authors:  P P Humphrey
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

2.  Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect.

Authors:  P R Saxena
Journal:  Eur J Pharmacol       Date:  1974-06       Impact factor: 4.432

3.  Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart.

Authors:  J R Fozard; A T Ali
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

4.  Letter: Comparison of the blocking effects of antagonists of adrenaline and 5-hydroxytryptamine on their mutual receptors.

Authors:  B D Görlitz; H H Frey
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

5.  Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.

Authors:  E Apperley; W Feniuk; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

6.  Cerebrovascular responses to subarachnoid blood and serotonin in the monkey.

Authors:  D P Boisvert; B K Weir; T R Overton; R J Reiffenstein; M G Grace
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

7.  Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

Authors:  L M Starling; D J Boullin; D G Grahame-Smith; C B Adams; R S Gye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  5-Hydroxytryptamine receptors. Contractile activity and mode of inhibition by methysergide in mammalian intracranial and extracranial vessels.

Authors:  J C Lamar; L Edvinsson
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-02

10.  Vascular smooth muscle response to fibrinogen degradation products and 5-hydroxytryptamine: possible role in cerebral vasospasm in man.

Authors:  C Forster; E T Whalley; J Mohan; J Dutton
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

View more
  6 in total

1.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites.

Authors:  E Hamel; D Bouchard
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

3.  Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

Review 4.  5-HT2 receptor antagonists and migraine therapy.

Authors:  E J Mylecharane
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

5.  5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery.

Authors:  A A Parsons; E T Whalley; W Feniuk; H E Connor; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

6.  Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery.

Authors:  P B Bradley; P P Humphrey; R H Williams
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.